Table 5.
Item 1 | Inclusion Level of WCG (g/kg DM) |
SEM | p-Value 2 | |||||
---|---|---|---|---|---|---|---|---|
0 | 30 | 60 | 90 | 120 | L | Q | ||
SFA | 13,552 | 12,352 | 14,454 | 12,204 | 12,926 | 1114 | 0.70 | 0.90 |
MUFA | 14,714 | 12,835 | 14,277 | 11,365 | 13,014 | 1592 | 0.36 | 0.66 |
PUFA | 1824 | 1768 | 2263 | 1982 | 1933 | 92.04 | 0.17 | 0.04 |
BCFA | 146 | 107 | 158 | 132 | 120 | 16.52 | 0.63 | 0.74 |
MUFA:SFA | 1.1 | 1.0 | 0.9 | 0.9 | 1.0 | 0.05 | 0.15 | 0.27 |
PUFA:SFA | 0.13 | 0.15 | 0.16 | 0.17 | 0.15 | 0.01 | 0.31 | 0.27 |
DFA | 21,637 | 19,256 | 22,694 | 18,300 | 19,987 | 1847 | 0.49 | 0.96 |
Neutral | 5165 | 4713 | 6202 | 5018 | 5106 | 375 | 0.88 | 0.28 |
Total | 32,576 | 29,229 | 33,464 | 27,733 | 30,206 | 2800 | 0.51 | 0.87 |
Ʃ-6 | 385 | 378 | 472 | 413 | 398 | 30.40 | 0.55 | 0.17 |
Ʃ-3 | 158 | 131 | 169 | 138 | 112 | 17.17 | 0.15 | 0.32 |
omega-6:omega-3 | 2.5 | 3.1 | 2.9 | 3.1 | 3.6 | 0.30 | 0.03 | 0.90 |
Atherogenicity index | 0.6 | 0.6 | 0.5 | 0.6 | 0.6 | 0.02 | 0.54 | 0.19 |
Thrombogenicity index | 1.6 | 1.7 | 1.7 | 1.8 | 1.7 | 0.07 | 0.15 | 0.40 |
Hypocholesterolemic (h) | 14,738 | 12,950 | 14,620 | 11,752 | 13,073 | 1454 | 0.35 | 0.76 |
Hypercholesterolemic (H) | 8319 | 8238 | 8101 | 7009 | 7736 | 977 | 0.43 | 0.85 |
h:H index | 1.9 | 1.8 | 1.9 | 1.8 | 1.8 | 0.05 | 0.26 | 0.63 |
Δ9-desaturase C16 | 7.8 | 7.1 | 7.0 | 7.1 | 7.0 | 0.37 | 0.14 | 0.42 |
Δ9-desaturase C18 | 71.3 | 70.0 | 66.8 | 67.0 | 68.6 | 2.07 | 0.24 | 0.26 |
Elongase | 70.6 | 70.1 | 71.6 | 70.7 | 70.0 | 0.74 | 0.77 | 0.28 |
1 SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid; DFA, desirable fatty acids; Ʃ-6, sum of omega-6 fatty acids; Ʃ-3, sum of omega-3 fatty acids; h:H, hypocholesterolemic to hypercholesterolemic FA ratio (h:H) index; 2 L = linear; Q = quadratic; significant at p < 0.05.